跳至主要内容
临床试验/ISRCTN45662651
ISRCTN45662651已完成不适用

Effect of simvastatin on endothelial dysfunction, fibrinolysis, coagulation and inflammation after aneurysmal subarachnoid hemorrhage

Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 30 人开始时间: 2006年6月29日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with clinical symptoms and signs of SAH with an aneurysmal bleeding pattern on the initial computerised tomography (CT) scan. CT scan has to be performed within 48 hours after SAH onset
  • 2. Patients with a perimesencephalic hemorrhage pattern on the initial CT scan while computed tomographic angiography (CTA) or conventional angiography has shown an appropriate aneurysm. CTA or angiography has to be performed within 48 hours after SAH onset
  • 3. If CT scan is negative while there is evidence of bleeding in the cerebrospinal fluid (xanthochromia) and the CT-angiography has shown an aneurysm

排除标准

  • 1. Under 18 years of age
  • 2. A time lapse of more than 48 hours after SAH onset
  • 3. Patients using aspirin or warfarin
  • 4. Patients already using statins
  • 5. Contra-indication for simvastatin (active liver disease, liver transaminase more than three times the normal upper limit, myopathy)
  • 6. Kidney insufficiency
  • 7. If death appears imminent
  • 8. Pregnancy or lactation

研究者

发起方
Academic Medical Centre (AMC) (The Netherlands)

相似试验

Effect of simvastatin on endothelial dysfunction,... | 临床试验